| Application no. and date | 11700669.2 (espacenet) (Federated) (European Patent Register), 20110121 | | Patent/reg. no. and date | DK/EP 2525807, 20141112 | | Publication date | 20121128 | | Priority no. and date | EP 10305070, 20100121 | | EP pub. no. and date |
EP 2525807 20121128 | | Effective date | | | Applicant/owner | SANOFI, 54 rue La Boétie
75008 Paris, FR | | Applicant ref. no. | DE2010/012EP-EPT | | Inventor | DREYER, Matthias, Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
HABERMANN,Paul, Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
SCHAEFER, Hans-Ludwig, Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
SOMMERFELD, Mark, Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
BOSCHEINEN, Oliver, Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
RAO, Ercole, Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/18 (2006.01) , A61K 38/26 (2006.01) , A61P 3/00 (2006.01) | | Title | Farmaceutisk præparat til behandling af et metabolisk syndrom | | Int. application no. | EP2011050793 | | Int. publication no. | WO2011089203 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
